Literature DB >> 9541372

Health-related quality of life in men with erectile dysfunction.

M S Litwin1, R J Nied, N Dhanani.   

Abstract

OBJECTIVE: To assess health-related quality of life (HRQOL) in men with erectile dysfunction.
DESIGN: Descriptive survey with general and disease-specific measures. The instrument contained three established, validated HRQOL measures, a validated comorbidity checklist, and sociodemographics. The RAND 36-Item Health Survey 1.0 (SF-36) was used to assess general HRQOL. Sexual function and sexual bother were assessed using the UCLA Prostate Cancer Index. The marital interaction scale from the Cancer Rehabilitation Evaluation System Short Form (CARES-SF) was used to assess each patient's relationship with his sexual partner.
SETTING: Urology clinics at a university medical center and the affiliated Veterans Affairs (VA) Medical Center. PARTICIPANTS: Thirty-five (67%) of 54 consecutive university patients presenting for erectile dysfunction and 22 (42%) of 52 VA patients who were awaiting a previously prescribed vacuum erection device participated. MAIN
RESULTS: The university respondents scored slightly lower than population normals in social function, role limitations due to emotional problems, and emotional well-being. The VA respondents scored lower than expected in all eight domains. Scores for the VA population were significantly lower than those for the university population in physical function, role limitations due to physical problems, bodily pain, and social function. A significant correlation was seen between marital interaction and sexual function (r = -.33, p = .01) but not between marital interaction and sexual bother (r = -.15, p = .26) in the total sample. Sexual function also correlated significantly with general health perceptions (r = .34, p = .01), role limitations due to physical problems (r = .29, p = .03), and role limitations due to emotional problems (r = .30, p = .03). Sexual bother did not correlate with any of the general HRQOL domains. Affluent men reported better sexual function (p = .03).
CONCLUSIONS: The emotional domains of the SF-36 are associated with more profound impairment than are the physical domains in men with erectile dysfunction. Erectile dysfunction and the bother it causes are discrete domains of HRQOL and distinct from each other in these patients. With increased attention to patient-centered medical outcomes, greater emphasis has been placed on such variables as HRQOL. This should be particularly true for a patient-driven symptom, such as erectile dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9541372      PMCID: PMC1496922          DOI: 10.1046/j.1525-1497.1998.00050.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  Assessment of quality-of-life outcomes.

Authors:  M A Testa; D C Simonson
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

2.  Practice trends of American urologists in the treatment of impotence, incontinence and infertility.

Authors:  W F Gee; H L Holtgrewe; P C Albertsen; M S Litwin; M J Manyak; M P O'Leary; M R Painter; R T Blizzard; R B Fenninger; L Emmons
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

3.  Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.

Authors:  H Padma-Nathan; W J Hellstrom; F E Kaiser; R F Labasky; T F Lue; W E Nolten; P C Norwood; C A Peterson; R Shabsigh; P Y Tam; V A Place; N Gesundheit
Journal:  N Engl J Med       Date:  1997-01-02       Impact factor: 91.245

4.  Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction.

Authors:  S Gheorghiu; M Godschalk; A Gentili; T Mulligan
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

5.  Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery.

Authors:  H Hedlund; K E Andersson
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

6.  Long-term efficacy of a new formulation of prostaglandin E1 as treatment for erectile failure.

Authors:  M Godschalk; D Gheorghiu; J Chen; P G Katz; T Mulligan
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

Review 7.  The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience.

Authors:  H Porst
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

8.  Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

Authors:  A R Helgason; M Fredrikson; J Adolfsson; G Steineck
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-04-30       Impact factor: 7.038

9.  Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence.

Authors:  A A Sidi; P K Reddy; K K Chen
Journal:  J Urol       Date:  1988-08       Impact factor: 7.450

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more
  59 in total

1.  Exploring the efficacy of support groups for men with prostrate cancer.

Authors:  B A Weber; B L Roberts; G J McDougall
Journal:  Geriatr Nurs       Date:  2000 Sep-Oct       Impact factor: 2.361

Review 2.  Female low sexual desire and sexually transmitted infections.

Authors:  D Goldmeier
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

3.  Health-related quality of life in a UK-based population of men with erectile dysfunction.

Authors:  Julian F Guest; Roben Das Gupta
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Partners' long-term appraisal of their caregiving experience, marital satisfaction, sexual satisfaction, and quality of life 2 years after prostate cancer treatment.

Authors:  Janet K Harden; Martin G Sanda; John T Wei; Hossein Yarandi; Larry Hembroff; Jill Hardy; Laurel L Northouse
Journal:  Cancer Nurs       Date:  2013 Mar-Apr       Impact factor: 2.592

5.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

6.  ED and quality of life in CABG patients: an intervention study using PRECEDE-PROCEED educational program.

Authors:  S Pournaghash-Tehrani; S Etemadi
Journal:  Int J Impot Res       Date:  2013-06-13       Impact factor: 2.896

7.  Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model.

Authors:  Xuefeng Qiu; Guiting Lin; Zhongcheng Xin; Ludovic Ferretti; Haiyang Zhang; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2012-12-17       Impact factor: 3.802

8.  Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction.

Authors:  Ridwan Shabsigh; Joel Kaufman; Michelle Magee; Dana Creanga; David Russell; Meeta Budhwani
Journal:  BMC Urol       Date:  2010-11-05       Impact factor: 2.264

9.  Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects.

Authors:  A Gatti; E Mandosi; M Fallarino; A Radicioni; E Morini; F Maiani; V Trischitta; A Lenzi; S Morano
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

10.  Translation and validation of the Korean version of MUDI and MUSIQ with urinary incontinent older men.

Authors:  Young Mi Lim; Jaemann Song; Heeyoung Oh
Journal:  Yonsei Med J       Date:  2008-02-24       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.